Thank you, Mr. Nakagawa.
Ms. Sanders, in your presentation, you said something that is very serious in my opinion. It pertains to the following:
While we recognize that there will always be tension between the pharmaceutical industry and CDR, [...]
So that means that there will always be a completely irreconcilable difference between what the industry wants and what the various legislatures or CDR partners want. Your opinion on the matter is very harsh. Could you explain why this is irreconcilable?